Australian Prescriber

An overview of how to choose an oral anticoagulant for a patient with atrial fibrillation or venous thromboembolism, when and how to monitor therapy, and how to manage bleeding in patients taking direct-acting oral anticoagulants.

New Australasian consensus recommendations for the screening and diagnosis of gestational diabetes have been published. This article covers the updated diagnostic criteria and guidance on early testing, as well as pharmacological therapies for gestational diabetes.

Counselling patients about sun protection is an important preventive health strategy. Health professionals are ideally placed to deliver evidence-based advice and dispel misconceptions about sun protection.

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease. Edaravone is a new drug approved for adults with ALS within 2 years of disease onset.

Complement inhibitors have transformed management and outcomes for patients with paroxysmal nocturnal haemoglobinuria. Iptacopan is the first oral complement inhibitor and can potentially inhibit both intra- and extra-vascular complement-mediated haemolysis.

Lebrikizumab is a new monoclonal antibody developed for the treatment of atopic dermatitis in adults and adolescents whose symptoms are not adequately controlled by topical therapies.